bangkok r.i.a lab .co., ltd.

What bangkok r.i.a lab .co., ltd. does

Bangkok R.I.A. Lab Co., Ltd. is a Thai clinical diagnostics company founded in 1982 by Prof. Dr. Ninlawan Pecharaburanin as Thailand's first private reference laboratory. The company operates three integrated divisions: BRIA LAB provides clinical reference testing across more than 700 diagnostic service types; Pacific Biotech, a subsidiary, develops and distributes diagnostic test kits including PCR kits manufactured in partnership with Solgent; and BRIA Health Center operates clinic-based preventive health services for individual patients. The company serves a dual customer base of B2B reference testing clients (hospitals, clinics, and healthcare providers that outsource diagnostic work) and B2C patients seeking preventive screening, with international technology partnerships including BGI-Shenzhen for NIFTY non-invasive prenatal testing and Abbott for diagnostic platforms.

The company's technology portfolio spans conventional laboratory instrumentation, PCR-based molecular diagnostics, immunoassays, and genetic screening, supported by an extensive quality and regulatory framework including ISO 9001, ISO 13485, ISO 27001, ISO 15189, Thai FDA GMP, Biotin Interference Free certification, and Westgard Sigma Re-Verification. The vertical integration through Pacific Biotech differentiates the company from pure-play reference laboratories by adding a manufacturing and external distribution revenue stream. Geographic footprint is concentrated in Thailand, with headquarters in Bangkok and a branch in Chiang Mai opened in 2014, plus cross-border engagement via medical exhibitions in markets such as Myanmar.

Revenue is generated through three primary channels: fee-for-service diagnostic testing paid by hospitals, clinics, and patients; sale of diagnostic test kits through Pacific Biotech to external laboratories; and clinic-based preventive health packages sold directly to consumers via BRIA Health Center. Leadership transitioned in 2016 from the founder to CEO Mr. Tosapol Pichayayothin, with Mr. Thitiyuth Pichayayothin serving as Director, maintaining family ownership continuity. The 35+ year operating history provides brand recognition as a pioneer in Thailand's private diagnostic sector, though the company operates at a sub-scale relative to large regional laboratory chains.

Name

bangkok r.i.a lab .co., ltd.

Legal name

Bangkok R.I.A. Lab Co., Ltd.

Website

https://brianet.com

Company type

Private

Founded year

1982

Operating status

Operating

Short description

Thailand's first private reference laboratory, founded 1982, operating clinical diagnostic services, test kit manufacturing via Pacific Biotech, and preventive health clinics across Bangkok and Chiang Mai, serving hospitals, healthcare providers, and individual patients.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Clinical laboratory services
• Molecular diagnostics testing
• Prenatal genetic screening
• Rapid diagnostic test kits
• Health check-up programs

Headquarters

HQ city

Bangkok

HQ country

Thailand

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Clinical Laboratory Services: Revenue generated from diagnostic laboratory testing services including blood tests, pathology, molecular biology, and health check-up programs offered at BRIA Lab and BRIA Health Center facilities.
2. Diagnostic Test Kits: Revenue from manufacturing and distribution of rapid diagnostic kits including OraQuick HIV self-tests, lateral flow tests, ELISA tests, and PCR kits through Pacific Biotech subsidiary.
3. Specialized Genetic Testing: Revenue from NIFTY prenatal testing and other genetic tests performed in partnership with BGI-Shenzhen.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Bangkok R.I.A. Lab Co., Ltd. provides comprehensive clinical laboratory, pathology, and molecular biology diagnostic testing services through its BRIA LAB facility, offering over 700 types of diagnostic analyses. The company operates BRIA Health Center for individual health check-up programs and specialized diagnostic services (NIFTY prenatal testing, food intolerance testing, tumor marker screening, liver diagnostics, HIV drug resistance testing), and manufactures rapid diagnostic test kits (HIV, lateral flow, ELISA, PCR) through its Pacific Biotech subsidiary.

Product overview

Bangkok R.I.A. Lab Co., Ltd. (BRIA Group) operates a multi-segment medical diagnostics portfolio comprising three main divisions: BRIA LAB (core laboratory services offering over 700 diagnostic analyses including clinical lab, surgical pathology, and molecular biology), Pacific Biotech (rapid diagnostic test kit manufacturing and distribution including HIV, lateral flow, ELISA, and PCR tests), and BRIA Health Center (clinic services providing health check-ups and specialized tests including NIFTY prenatal screening, food intolerance testing via MicroArray, tumor marker screening, FibroTest/ActiTest liver diagnostics, and HIV drug resistance testing). The company serves customers across Thailand including through its Chiang Mai regional center.

Differentiator

Problem solved

Functional benefit

Brands

• Pacific Biotech: Diagnostic rapid test kits for pregnancy, infectious diseases (HIV, TB), drug abuse screening; ISO 9001, ISO 13485, Thai FDA GMP certified manufacturing
• BRIA Health Center
• NIFTY

Products and services

• BRIA LAB Clinical Laboratory Services Comprehensive medical diagnostic laboratory services including clinical chemistry blood testing, surgical pathology, and molecular biology analyses. The main laboratory brand offering over 700 types of diagnostic analyses to healthcare providers and individual patients.
• Pacific Biotech Diagnostic Test Kits Rapid diagnostic test kit manufacturing and distribution division producing OraQuick HIV Self-Test kits, Lateral Flow Tests, ELISA Tests, PCR Test kits, and providing OEM manufacturing services. Certified to ISO 9001:2008, ISO 13485:2012, and Thai FDA GMP standards. Targets medical distributors, clinics, and healthcare facilities.
• BRIA Health Center Health Check-up Programs Health check-up clinic offering nine tiered health screening programs (P1-P9) ranging from 1,800 THB to 13,380 THB, including general checkups, hepatitis screening, pre-wedding screening, and age-specific panels for women above 45. One-stop health screening for individual consumers.
• NIFTY Non-invasive Prenatal Test Non-invasive prenatal test (NIPT) using whole genome sequencing technology to detect cell-free fetal DNA (cffDNA) in maternal plasma, screening for trisomy 21, 18, and 13. Available for singleton, surrogacy, and twin pregnancies. Performed in partnership with BGI-Shenzhen Clinical Laboratories.
• Food Intolerance Test Food allergy and intolerance testing using MicroArray technology covering 221 types of food allergens. Identifies individual food sensitivities through blood-based immunological analysis.
• Tumor Marker Screening Cancer screening via blood test using US-sourced technology that can detect 11 tumor marker types and correlate them with specific organ cancers. Provides comprehensive cancer risk assessment in a single screening service.
• FibroTest/ActiTest Liver Diagnostics Non-invasive liver diagnostic using 6 biochemical markers providing METAVIR fibrosis staging and necro-inflammatory grading for patients with chronic liver diseases including Hepatitis C (HCV), Hepatitis B (HBV), Alcoholic Liver Disease (ALD), and Non-Alcoholic Fatty Liver Disease (NAFLD).
• HIV Drug Resistance Testing Molecular biology testing service for HIV drug resistance analysis, passed External Quality Assessment Schemes from Thailand's Department of Medical Sciences, Ministry of Public Health since July 2014. Supports HIV treatment regimen decisions for healthcare providers.

Quantifiable outcome

• Over 700 diagnostic service types available
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• BGI-Shenzhen Clinical LaboratoriescoreStrategic or Co-development Partner · 1 January 2016Partnership for NIFTY (Non-invasive Prenatal Testing) services. BGI provides the testing technology and laboratory analysis while Bangkok R.I.A. Lab serves as the regional collection center in Thailand. NIFTY test assesses fetal risk for trisomy 21, 18, and 13 using whole genome sequencing technology.
• Solgent Co., Ltd.coreTechnology or Integration · 28 May 2015Partnership with Korean molecular diagnostics manufacturer for PCR kit product launching. Solgent is one of the largest manufacturers and suppliers of medical technology in South Korea. Joint product launch ceremony held on May 28, 2015 at Chiang Mai International Exhibition and Convention Centre.
• Abbott Laboratories Ltd.coreTechnology or IntegrationTechnology and equipment partnership for diagnostic testing including cancer and tumor marker analysis. Joint educational meetings organized for doctors, nurses and laboratory officers on latest diagnostic technologies. Abbott provides diagnostic platforms and reagents used in BRIA Lab testing services.
• King Chulalongkorn Memorial HospitalcoreStrategic or Co-development PartnerAcademic medical partnership for NIFTY testing promotion with Maternal and Fetal Medicine Unit, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University. Joint special pricing campaigns for prenatal testing services.
• Phitsanuvet HospitalminorGTM or Marketing PartnerHealthcare provider partnership for organizing educational meetings on Genetic Testing for Cancer and Tumor Markers & Ovarian Cancer. BRIA Lab collaborated with Abbott Laboratories Ltd. to update doctors, nurses and laboratory officers on latest technology.
• NASTVAC Research Project (National Science and Technology Development Agency)coreStrategic or Co-development PartnerResearch funding support for nasal spray COVID-19 vaccine (NASTVAC) testing. Bangkok R.I.A. Lab donated 200,000 Baht on November 17, 2021 for human testing Phase 1 and Phase 2 trials conducted by BIOTEC (National Center for Genetic Engineering and Biotechnology).

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• BGI Genomics: BGI Genomics is a global genomics and NIPT powerhouse that supplies BRIA's NIFTY prenatal testing technology. As a far larger player offering clinical sequencing, reproductive health, and oncology testing at international scale, it represents both a key partner and a strategic incumbent whose roadmap shapes BRIA's premium test portfolio.
• Synlab: Synlab operates Europe's largest clinical laboratory network, providing reference diagnostics and medical testing to hospitals and physicians. Comparable to BRIA in core reference-lab positioning but at vastly greater scale, it serves as a strategic comparator for any regional or pan-Asian rollup ambitions.
• Sonic Healthcare: Sonic Healthcare is a major global diagnostics operator running reference laboratories and pathology services across Australia, Europe, and the US. It exemplifies a multi-region reference-lab business model and serves as a strategic scale benchmark for BRIA's long-term positioning.
• Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory services companies in the United States, providing routine and esoteric diagnostic testing. Comparable in business model (B2B reference lab, broad test menu) but operating at significantly greater scale than BRIA.
• Eurofins Scientific: Eurofins is one of the world's largest reference laboratory networks offering clinical diagnostics, food, and environmental testing. It represents the global reference-lab model at scale against which BRIA's regional ambition must be benchmarked, particularly for any expansion into industrial or food safety testing.
• Abbott Diagnostics: Abbott provides the immunoassay analyzers, reagents, and Biotin Interference Free / Westgard Sigma certifications underpinning BRIA's clinical lab operations. As a global diagnostics incumbent, Abbott competes broadly in IVD while also serving as BRIA's core technology partner, making it both supplier and strategic reference point.

Direct peers

• OraSure Technologies: OraSure Technologies develops and manufactures point-of-care diagnostic tests, including the OraQuick HIV Self-Test that Pacific Biotech distributes in Thailand. It is directly comparable as a rapid diagnostic kit manufacturer with overlapping HIV and infectious disease test portfolios.
• SD Biosensor: SD Biosensor is a South Korea-headquartered manufacturer of rapid diagnostic test kits, including HIV, COVID-19, and infectious disease tests. As a fellow Asian diagnostics kit manufacturer with comparable OEM and branded product lines, it is directly comparable to BRIA's Pacific Biotech manufacturing subsidiary.
• N Health (Bangkok): N Health provides medical laboratory and diagnostic services across Thailand, including clinical chemistry, immunology, microbiology, and molecular diagnostics for hospitals and clinics. It is the closest Thai-based direct competitor to BRIA's clinical lab business model and reference laboratory positioning.

Emerging players

• Solgent: Solgent is a South Korean molecular diagnostics manufacturer of PCR kits that has a documented co-launch partnership with Pacific Biotech. Comparable as a specialized PCR and molecular diagnostics producer with regional Asian reach relevant to BRIA's molecular biology expansion.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/briathailand
• Facebookfacebook.com/briagroup

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about bangkok r.i.a lab .co., ltd.